|
|
Central nervous system: clinical trials
A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor in the treatment of depression,
Acta Psychiatrica Scandinavica, 94, 404-410, (1996)
Double-blind randomized controlled study of the efficacy and tolerability of pirlindole, a reversible inhibitor of monoamine oxidase A, and mianserin, in the treatment of depression,
Human Psychopharmacology, 12, 41-46, (1997).
Multicentric open-label study of the efficacy and tolerability of citicoline in the treatment of acute cerebral infarction,
Current Therapeutic Research, 58(5), 309-316, (1997).
Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression,
Acta Psychiatrica Scandinavica, 96(2), 134-141, (1997).
|
